Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Cyclically Adjusted FCF per Share: ¥0.64 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600267 Zhejiang Hisun Pharmaceutical Co Ltd SHSE:600267
61 GF Score
Price ¥14.18
GF Value ¥8.75
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted FCF per Share?

Zhejiang Hisun Pharmaceutical Co SHSE:600267 +1.58% 61 Cyclically Adjusted FCF per Share is ¥0.64 as of Mar. 2026. GuruFocus rates SHSE:600267 with a GF Score™ of 61/100 and a GF Value™ of ¥8.75 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥0.282. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.64 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Hisun Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 82.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zhejiang Hisun Pharmaceutical Co was 47.40% per year. The lowest was -40.10% per year. And the median was -4.00% per year.

As of today (2026-08-15), Zhejiang Hisun Pharmaceutical Co's current stock price is ¥14.18. Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.64. Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 22.16.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Hisun Pharmaceutical Co was 113.43. The lowest was 15.23. And the median was 25.34.


Zhejiang Hisun Pharmaceutical Co  (SHSE:600267) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=14.18/0.64
=22.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Hisun Pharmaceutical Co was 113.43. The lowest was 15.23. And the median was 25.34.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Zhejiang Hisun Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.79 -0.48 -0.14 0.25 0.55

Zhejiang Hisun Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.44 0.45 0.55 0.64

SHSE:600267 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600267
61GF Score
Zhejiang Hisun Pharmaceutical Co Ltd SHSE:600267
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Hisun Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.282/116.3033*116.3033
=0.282

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Hisun Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.267 101.400 -0.306
201609 -0.083 102.400 -0.094
201612 -0.203 102.600 -0.230
201703 -0.313 103.200 -0.353
201706 -0.476 103.100 -0.537
201709 0.285 104.100 0.318
201712 0.283 104.500 0.315
201803 -0.005 105.300 -0.006
201806 -0.144 104.900 -0.160
201809 0.160 106.600 0.175
201812 -0.198 106.500 -0.216
201903 -0.326 107.700 -0.352
201906 0.178 107.700 0.192
201909 -0.246 109.800 -0.261
201912 0.004 111.200 0.004
202003 0.310 112.300 0.321
202006 0.003 110.400 0.003
202009 0.397 111.700 0.413
202012 0.217 111.500 0.226
202103 0.061 112.662 0.063
202106 0.000 111.769 0.000
202109 0.498 112.215 0.516
202112 0.386 113.108 0.397
202203 0.066 114.335 0.067
202206 0.538 114.558 0.546
202209 0.276 115.339 0.278
202212 0.462 115.116 0.467
202303 0.112 115.116 0.113
202306 0.338 114.558 0.343
202309 0.445 115.339 0.449
202312 0.120 114.781 0.122
202403 0.237 115.227 0.239
202406 0.372 114.781 0.377
202409 0.538 115.785 0.540
202412 0.546 114.893 0.553
202503 0.187 115.116 0.189
202506 0.764 114.907 0.773
202509 0.286 115.471 0.288
202512 0.182 115.832 0.183
202603 0.282 116.303 0.282

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.64 mean?
Zhejiang Hisun Pharmaceutical Co (SHSE:600267) has a Cyclically Adjusted FCF per Share of ¥0.64 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors.
Is Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Zhejiang Hisun Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.64. Overall, Zhejiang Hisun Pharmaceutical Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to ZTS?
Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted FCF per Share of ¥0.64 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors. Zhejiang Hisun Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co (SHSE:600267) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.75, compared to a current price of ¥14.18 — trading 62.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.64. Zhejiang Hisun Pharmaceutical Co's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zhejiang Hisun Pharmaceutical Co (SHSE:600267), the current Cyclically Adjusted FCF per Share is ¥0.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥14.18 is trading 62.1% above its estimated GF Value™ of ¥8.75. GuruFocus considers Zhejiang Hisun Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:600267:

  • Cyclically Adjusted FCF per Share: ¥0.64
  • GF Value™: ¥8.75 vs. price of ¥14.18 (62.1% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Hisun Pharmaceutical Co Business Description

Address No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
61GF Score

Get the complete analysis for SHSE:600267

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.18
Price
¥8.75
GF Value